Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease

Bibliographic Details
Main Authors:	Linn Oftedal, Johannes Lange, Kenn Freddy Pedersen, Aleksander Hagen Erga, Ingvild Dalen, Ole-Bjørn Tysnes, Guido Alves, Jodi Maple-Grødem
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Series:	Translational Neurodegeneration
Online Access:	https://doi.org/10.1186/s40035-023-00373-x

Similar Items

Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
by: Aleksander H. Erga, et al.
Published: (2018-02-01)

Parkinson’s disease clinical milestones and mortality
by: Maria Camila Gonzalez, et al.
Published: (2022-05-01)

Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach
by: Jodi Maple-Grødem, et al.
Published: (2023-10-01)

Cognitive Profile in Parkinson’s Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta
by: Zeynep Tufekcioglu, et al.
Published: (2023-10-01)

Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid
by: Linn Oftedal, et al.
Published: (2020-12-01)

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker Discovery
by: Ali Esfandiary, et al.
Published: (2022-04-01)

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease
by: Camilla Christina Pedersen, et al.
Published: (2021-07-01)

Excessive Daytime Sleepiness and REM Sleep Behavior Disorders in Parkinson's Disease: A Narrative Review on Early Intervention With Implications to Neuroprotection
by: Michaela D. Gjerstad, et al.
Published: (2018-11-01)

GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice
by: Martijn J. C. van der Lienden, et al.
Published: (2021-03-01)

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
by: Maria Kedariti, et al.
Published: (2022-07-01)

GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
by: Macarena Martínez-Bailén, et al.
Published: (2022-07-01)

Altered transcriptome-proteome coupling indicates aberrant proteostasis in Parkinson’s disease
by: Fiona Dick, et al.
Published: (2023-02-01)

First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors, and outcomes
by: Samantha Green, et al.
Published: (2021-10-01)

Norsk Parkinsonregister og biobank
by: Kenn Freddy Pedersen, et al.
Published: (2023-10-01)

Dermal fibroblasts from patients with Parkinson’s disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations [version 2; referees: 2 approved]
by: Lucy M Collins, et al.
Published: (2018-02-01)

Differential transcript usage in the Parkinson's disease brain.
by: Fiona Dick, et al.
Published: (2020-11-01)

The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease
by: Aleksander H. Erga, et al.
Published: (2023-04-01)

Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease” [Contemp. Clinic. Trials Commun. 32 (2023) 101080]
by: Aleksander H. Erga, et al.
Published: (2023-10-01)

Early Forms of <i>α</i>-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson’s Disease
by: Irene Hana Flønes, et al.
Published: (2022-05-01)

Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition
by: Gonzalo S. Nido, et al.
Published: (2020-04-01)

Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated loci
by: Johannes Jernqvist Gaare, et al.
Published: (2020-01-01)

Impulse-Control Disorders in Parkinson’s Disease: A Meta-Analysis and Review of Case–Control Studies
by: Helge Molde, et al.
Published: (2018-05-01)

Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain
by: Lilah Toker, et al.
Published: (2021-05-01)

Synthesis of “<i>All-Cis”</i> Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
by: Maria Giulia Davighi, et al.
Published: (2020-10-01)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
by: Adahir Labrador-Garrido, et al.
Published: (2023-10-01)

Early constipation predicts faster dementia onset in Parkinson’s disease
by: M. Camacho, et al.
Published: (2021-05-01)

Personality and substance use disorder: Characteristics as measured by NEO-personality inventory–revised
by: Elise Constance Fodstad, et al.
Published: (2022-11-01)

Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention
by: Aleksander H. Erga, et al.
Published: (2023-10-01)

Ultra-deep whole genome bisulfite sequencing reveals a single methylation hotspot in human brain mitochondrial DNA
by: Romain Guitton, et al.
Published: (2022-08-01)

Cognitive decline in patients with Parkinson’s disease
by: Denisa Floriana Vasilica Pirscoveanu, et al.
Published: (2017-12-01)

The interdependence of substance use, satisfaction with life, and psychological distress: a dynamic structural equation model analysis
by: Fredrik D. Moe, et al.
Published: (2024-02-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2019-11-01)

Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
by: Christian Dölle, et al.
Published: (2016-11-01)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Dementia and functional decline in patients with Parkinson's disease
by: Florindo Stella, et al.

Who fears and who welcomes population decline?
by: Hendrik P. Van Dalen, et al.
Published: (2011-08-01)

Correction to: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2020-01-01)

Capturing Subjective Mild Cognitive Decline in Parkinson’s Disease
by: Sara Rosenblum, et al.
Published: (2022-06-01)

Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease
by: Katherine Longardner, et al.
Published: (2020-09-01)

Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson’s disease and atypical parkinsonism
by: Bradley J. Wilkes, et al.
Published: (2023-06-01)